Catheter Precision raises $1.5M cash, issues 3,000 Series B Preferred shares and warrants

Catheter Precision, Inc.

Series B Preferred: 3,000 shares at $1,000 stated value; 1,500 sold for $1.5M cash, 1,500 issued for QHSLab notes.
Cash investors: C/M Capital (600 shares, 1.71M warrants), WVP/C/M Capital (400 shares, 1.14M warrants).
Mercer Street receives 2,000 Series B shares and 1.43M warrants in exchange for ~$1.6M defaulted QHSLab notes.
Conversion price $0.35/share; ~2,858 common shares per preferred share; warrants $0.50, 5.5-year term, callable above $1.50 VWAP.
Stockholder approval needed for conversion beyond 19.99% of outstanding and warrant exercise; meeting July 25, 2025.

item 1.01 item 2.01 item 3.02 item 3.03 item 5.03 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.